The treatment group that was given the high-concentration full-spectrum Ashwagandha root extract exhibited a significant reduction (P<0.0001) in scores on all the stress-assessment scales on Day 60, relative to the placebo group. The serum cortisol levels were substantially reduced (P=0.0006) in the Ashwagandha group, relative to the placebo group. [...] The findings of this study suggest that a high-concentration full-spectrum Ashwagandha root extract safely and effectively improves an individual's resistance towards stress and thereby improves self-assessed quality of life.
Read the Abstract
Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Phytomedicine. 2000 Dec;7(6):463-9. PubMed PMID: 11194174.
Read the AbstractMishra LC, Singh BB, Dagenais S. Altern Med Rev. 2000 Aug;5(4):334-46. Review. PubMed PMID: 10956379.
Read the AbstractCooley K, Szczurko O, Perri D, Mills EJ, Bernhardt B, Zhou Q, Seely D. PLoS One. 2009 Aug 31;4(8):e6628. doi: 10.1371/journal.pone.0006628. PubMed PMID: 19718255; PubMed Central PMCID: PMC2729375.
Read the AbstractJain S, Shukla SD, Sharma K, Bhatnagar M. Phytother Res. 2001 Sep;15(6):544-8. PubMed PMID: 11536389.
Read the AbstractKuboyama T, Tohda C, Komatsu K. Br J Pharmacol. 2005 Apr;144(7):961-71. PubMed PMID: 15711595; PubMed Central PMCID: PMC1576076.
Read the AbstractThe results showed that L-Theanine intake resulted in a reduction in the heart rate (HR) and salivary immunoglobulin A (s-IgA) responses to an acute stress task relative to the placebo control condition. Moreover, analyses of heart rate variability indicated that the reductions in HR and s-IgA were likely attributable to an attenuation of sympathetic nervous activation. Thus, it was suggested that the oral intake of L-Theanine could cause anti-stress effects via the inhibition of cortical neuron excitation.
Read the Abstract
Nathan PJ, Lu K, Gray M, Oliver C. J Herb Pharmacother. 2006;6(2):21-30. Review. PubMed PMID: 17182482.
Read the AbstractSugiyama T, Sadzuka Y, Tanaka K, Sonobe T. Toxicol Lett. 2001 Apr 30;121(2):89-96. PubMed PMID: 11325559.
Read the AbstractSugiyama T, Sadzuka Y. Biochim Biophys Acta. 2003 Dec 5;1653(2):47-59. Review. PubMed PMID: 14643924.
Read the AbstractWakabayashi C, Numakawa T, Ninomiya M, Chiba S, Kunugi H. Psychopharmacology (Berl). 2012 Feb;219(4):1099-109. doi: 10.1007/s00213-011-2440-z. Epub 2011 Aug 23. PubMed PMID: 21861094.
Read the AbstractYokogoshi H, Kobayashi M, Mochizuki M, Terashima T. Neurochem Res. 1998 May;23(5):667-73. PubMed PMID: 9566605.
Read the AbstractWhole Passiflora extract induced prominent, dose-dependent direct GABA(A) currents in hippocampal slices, but the expected modulation of synaptic GABA(A) currents was not seen. GABA was found to be a prominent ingredient of Passiflora extract, and GABA currents were absent when amino acids were removed from the extract.
Read the Abstract
Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. J Clin Pharm Ther. 2001 Oct;26(5):363-7. PubMed PMID: 11679026.
Read the AbstractBarbosa PR, Valvassori SS, Bordignon CL Jr, Kappel VD, Martins MR, Gavioli EC, Quevedo J, Reginatto FH. J Med Food. 2008 Jun;11(2):282-8. doi: 10.1089/jmf.2007.722. PubMed PMID: 18598170.
Read the AbstractGrundmann O, Wang J, McGregor GP, Butterweck V. Planta Med. 2008 Dec;74(15):1769-73. doi: 10.1055/s-0028-1088322. Epub 2008 Nov 12. PubMed PMID: 19006051.
Read the AbstractMovafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. Anesth Analg. 2008 Jun;106(6):1728-32. doi: 10.1213/ane.0b013e318172c3f9. PubMed PMID: 18499602.
Read the AbstractSeveral studies have suggested that exogenous administration of the serotonin precursor 5-hydroxytryptophan (5-HTP) can result in the ectopic production of serotonin in dopaminergic neurons and a concomitant reduction in dopamine release. [...] 5-HTP significantly lengthened the average time needed to complete each of the 10 trials of the TOL. 5-HTP did not affect accuracy on this task. [...] Oral exogenous 5-HTP disrupts dopaminergic function in the human forebrain.
Read the Abstract
Angst J, Woggon B, Schoepf J. Arch Psychiatr Nervenkr (1970). 1977 Oct 11;224(2):175-86. PubMed PMID: 336002.
Read the AbstractBirdsall TC. Altern Med Rev. 1998 Aug;3(4):271-80. Review. PubMed PMID: 9727088.
Read the AbstractByerley WF, Judd LL, Reimherr FW, Grosser BI. J Clin Psychopharmacol. 1987 Jun;7(3):127-37. Review. PubMed PMID: 3298325.
Read the AbstractDe Benedittis G, Massei R. J Neurosurg Sci. 1985 Jul-Sep;29(3):239-48. PubMed PMID: 3913752.
Read the AbstractJangid P, Malik P, Singh P, Sharma M, Gulia AK. Asian J Psychiatr. 2013 Feb;6(1):29-34. doi: 10.1016/j.ajp.2012.05.011. Epub 2012 Jul 12. PubMed PMID: 23380314.
Read the AbstractZmilacher K, Battegay R, Gastpar M. Neuropsychobiology. 1988;20(1):28-35. PubMed PMID: 3265988.
Read the AbstractThe results showed that the 600-mg dose of Melissa ameliorated the negative mood effects of the DISS [Defined Intensity Stressor Simulation], with significantly increased self-ratings of calmness and reduced self-ratings of alertness. In addition, a significant increase in the speed of mathematical processing, with no reduction in accuracy, was observed after ingestion of the 300-mg dose.
Read the Abstract
Awad R, Levac D, Cybulska P, Merali Z, Trudeau VL, Arnason JT. Can J Physiol Pharmacol. 2007 Sep;85(9):933-42. PubMed PMID: 18066140.
Read the AbstractKennedy DO, Little W, Haskell CF, Scholey AB. Phytother Res. 2006 Feb;20(2):96-102. PubMed PMID: 16444660.
Read the AbstractKennedy DO, Wake G, Savelev S, Tildesley NT, Perry EK, Wesnes KA, Scholey AB. Neuropsychopharmacology. 2003 Oct;28(10):1871-81. PubMed PMID: 12888775.
Read the AbstractMüller SF, Klement S. Phytomedicine. 2006 Jun;13(6):383-7. Epub 2006 Feb 17. PubMed PMID: 16487692.
Read the Abstract